Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1154-2013Class II

Nova StatStrip Xpress Glu-Test Strips (Glucose test strips) Catalog # 51493 (UK Only)

Nova Biomedical Corporation / initiated 2013-02-25 / Terminated / root cause: manufacturing process

Nova Biomedical Corporation began a recall of Nova StatStrip Xpress Glu-Test Strips (Glucose test strips) Catalog # 51493 (UK Only) on . FDA classified it as Class II and gives the reason as "Glucose test strips reports no result message when tested". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1154-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Nova Biomedical Corporation
Product
Nova StatStrip Xpress Glu-Test Strips (Glucose test strips) Catalog # 51493 (UK Only)
Product code
CGA Glucose Oxidase, Glucose
Reason for recall
Glucose test strips reports no result message when tested
Root cause tag
manufacturing process
FDA root cause
Process design
Action
The firm, Nova Biomedical, sent an "Urgent Field Safety Notice 01-13SS" dated March 18, 2013 and US customers notification by phone contact and to the International customers including a Faxback Form to be communicated to and sent to Nova Biomedical Subsidiary by two methods of delivery (Email and Phone Call). The customers were instructed to INVALIDATE the Nova StatStrip Glucose Test Strip lots indicated in the list on all StatStrip meters within your institute; REPLACE all Nova StatStrip Glucose Test Strips from the indicated lots with replacement test strips provided by Nova; REMOVE all unused boxes of the Nova StatStrip Glucose Test Strip lots indicated from all locations within your institute; RETURN all unused boxes of the Nova StatStrip Glucose Test Strips lots indicated to Nova Biomedical U.K. or your local Nova distributor following the country specific instructions provided by your authorized Nova representative, and complete and return the Fax-Back Form via email or FAX to your Regional Service Manager at 781-8914806. On April 08, 2013, the firm expanded the recall notification to include one additional test strip lot #0313021309 which was shipped under two catalog numbers(Catalog # 42214 and Catalog# 51493). US Notification by phone contact with key customer contact facilitated by Senior Manger of Technical Support Services. International - Field Safety Notice and Faxback Form is being communicated to and sent to Nova Biomedical Subsidiary by two methods of delivery (Email and Phone Call). Questions regarding this notice should be directed to the following Nova Biomedical EU Authorized Representative at: Nova Biomedical Innovation House, Aston Lane South Runcorn,WA7 3FY Telephone: + 44 1244 287087 Email: [email protected]. or US at (781) 894-0800.
Quantity in commerce
2200 cases
Distribution
Worldwide distribution: USA (nationwide) including states of: CA, IL, KY,NY, WV and countries of: United Kingdom and Italy.
Product codes and lots
Lot 0312361309, Expires 6/30/2015 Expanded recall: Lot 0313021309, Expires 07/31/2015

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1154-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1153-2013Class IITerminatedVoluntary: Firm initiated
Z-1154-2013Class IITerminatedVoluntary: Firm initiated